ROC analysis showed SNHG9 has high sensitivity and specificity for identification of hepatoblastoma tumors, thus it could be a potential diagnostic biomarker, and therapeutic target for the treatment and early diagnosis of HB patients. Here, SNHG9 is linked to hepatoblastoma.